Biblio Discovery — Demo Discovery Service

23 hasil untuk "Steven Julious"

Menampilkan 1–20 · 0,70 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Understanding Variation in Sets of N-of-1 Trials.

    Artur Araujo; Steven Julious; Stephen Senn

    PLoS ONE, Vol. 11 No. 12 · 2016 · Inggris · DOAJ Scopus

    A recent paper in this journal by Chen and Chen has used computer simulations to examine a number of approaches to analysing sets of n-of-1 trials. We have examined such designs using a more theoretical approach based on considering the purpose of analysis and the structure as regards randomisation…

    Juga tersedia di: PLOS

  2. Artikel Jurnal

    A review of UK publicly funded non-inferiority trials: is the design more inferior than it should be?

    Nikki Totton; Steven Julious; Stephen Walters dkk.

    Trials, Vol. 25 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract Background The number of non-inferiority (NI) trials, those aiming to show a new treatment is no worse than a comparator, is increasing. However, their added complexity over superiority trials can create confusion. Most guidance and reviews to date have an industry focus with research…

  3. Artikel Jurnal

    The development of a set of key points to aid clinicians and researchers in designing and conducting n-of-1 trials

    Robin Chatters; Olivia Hawksworth; Steven Julious dkk.

    Trials, Vol. 25 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract Introduction n-of-1 trials are undertaken to optimise the evaluation of health technologies in individual patients. They involve a single patient receiving treatments, both interventional and control, consecutively over set periods of time, the order of which is decided at random. Although…

  4. Artikel Jurnal

    How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis

    Laura Flight; Steven Julious; Alan Brennan dkk.

    Trials, Vol. 21 No. 1 · 2020 · Inggris · DOAJ Scopus

    Abstract Introduction Adaptive designs offer a flexible approach, allowing changes to a trial based on examinations of the data as it progresses. Adaptive clinical trials are becoming a popular choice, as the prudent use of finite research budgets and accurate decision-making are priorities for…

  5. Artikel Jurnal

    A review of sample sizes for UK pilot and feasibility studies on the ISRCTN registry from 2013 to 2020

    Nikki Totton; Jinfeng Lin; Steven Julious dkk.

    Pilot and Feasibility Studies, Vol. 9 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Background Pilot and feasibility studies provide information to be used when planning a full trial. A sufficient sample size within the pilot/feasibility study is required so this information can be extracted with suitable precision. This work builds upon previous reviews of pilot and…

  6. Artikel Jurnal

    A proposal for using benefit-risk methods to improve the prominence of adverse event results when reporting trials

    Nikki Totton; Ed Waddingham; Ruth Owen dkk.

    Trials, Vol. 25 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract Adverse events suffer from poor reporting within randomised controlled trials, despite them being crucial to the evaluation of a treatment. A recent update to the CONSORT harms checklist aims to improve reporting by providing structure and consistency to the information presented. We…

  7. Artikel Jurnal

    Value-adaptive clinical trial designs for efficient delivery of publicly funded trials - a discussion of methods, case studies, opportunities and challenges

    Laura Flight; Alan Brennan; Stephen E. Chick dkk.

    BMC Medical Research Methodology, Vol. 25 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Background Value-adaptive designs for clinical trials are a novel set of emerging methods for delivering greater value for clinical research. There is increasing interest in using them within publicly funded health systems. A value-adaptive design permits ‘in progress’ changes to be made…

  8. Artikel Jurnal

    A descriptive study of samples sizes used in agreement studies published in the PubMed repository

    Oscar Han; Hao Wei Tan; Steven Julious dkk.

    BMC Medical Research Methodology, Vol. 22 No. 1 · 2022 · Inggris · DOAJ Scopus

    Abstract Introduction A sample size justification is required for all studies and should give the minimum number of subjects to be recruited for the study to achieve its primary objective. The aim of this review is to describe sample sizes from agreement studies with continuous or categorical…

  9. Artikel Jurnal

    Utilising benefit-risk assessments within clinical trials—a protocol for the BRAINS project

    Nikki Totton; Steven Julious; Dyfrig Hughes dkk.

    Trials, Vol. 22 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract Background Depending on the treatment to be investigated, a clinical trial could be designed to assess objectives of superiority, equivalence or non-inferiority. The design of the study is affected by many different elements including the control treatment, the primary outcome and…

  10. Artikel Jurnal

    A methodological review of randomised n-of-1 trials

    Olivia Hawksworth; Robin Chatters; Steven Julious dkk.

    Trials, Vol. 25 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract Background n-of-1 trials are a type of crossover trial designed to optimise the evaluation of health technologies in individual patients. This trial design may be considered for the evaluation of health technologies in rare conditions where fewer patients are available to take part in…

  11. Artikel Jurnal

    Blinding of study statisticians in clinical trials: a qualitative study in UK clinical trials units

    Mais Iflaifel; Christopher Partlett; Jennifer Bell dkk.

    Trials, Vol. 23 No. 1 · 2022 · Inggris · DOAJ Scopus

    Abstract Background Blinding is an established approach in clinical trials which aims to minimise the risk of performance and detection bias. There is little empirical evidence to guide UK clinical trials units (CTUs) about the practice of blinding statisticians. Guidelines recommend that…

  12. Artikel Jurnal

    Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with Recessive Dystrophic Epidermolysis Bullosa (MissionEB): a qualitative sub study of a randomised, double-blind, placebo controlled, crossover, phase 3 trial

    Katie Biggs; Shamila Ditta; Maria L. Bageta dkk.

    Orphanet Journal of Rare Diseases, Vol. 21 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract Background Recessive Dystrophic Epidermolysis Bullosa (RDEB) is a rare genetic skin condition causing fragile skin, blistering, and scarring. It leads to chronic pain, slow wound healing, and severe limitations, profoundly impacting patient and family quality of life. Umbilical cord…

  13. Artikel Jurnal

    Sample size calculations for pilot cluster-randomised controlled trial: a review 2010–2020

    Rebecca M. Simpson; Jen Lewis; Michael J. Campbell dkk.

    Pilot and Feasibility Studies, Vol. 12 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract Background There is no recommended guidance on appropriate sample sizes for pilot cluster-randomised controlled trials (cRCTs). Pilot trials should not aim to demonstrate efficacy, and achieving power should not be used to justify the sample size. However, the CONSORT extension for pilot…

  14. Artikel Jurnal Teks lengkap

    IMPlementing IMProved Asthma self-management as RouTine (IMP 2 ART) in UK primary care: An internal pilot for a cluster randomised controlled trial

    Kirstie McClatchey; Daisy Bertram; Atena Barat dkk.

    PLOS One, Vol. 21 No. 3 · 2026 · Inggris · PLOS Scopus

    Introduction: Supported self-management that includes a personalised asthma action plan and regular professional review, reduces unscheduled consultations, and improves asthma outcomes and quality of life. However, despite unequivocal inter/national guideline recommendations, supported…

    Juga tersedia di: DOAJ, DOAJ

  15. Artikel Jurnal

    Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial

    Dinesh Selvarajah; Jennifer Petrie; David White dkk.

    Trials, Vol. 19 No. 1 · 2018 · Inggris · DOAJ Scopus

    Abstract Background The number of people with diabetes is growing rapidly. Diabetes can cause nerve damage leading to severe pain in the feet, legs and hands, which is known as diabetic peripheral neuropathic pain (DPNP). In the UK, the National Institute for Health and Care Excellence (NICE)…

  16. Artikel Jurnal

    Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCT

    Rebecca Palmer; Munyaradzi Dimairo; Nicholas Latimer dkk.

    Health Technology Assessment, Vol. 24 No. 19 · 2020 · Inggris · DOAJ Scopus

    Background: People with aphasia may improve their communication with speech and language therapy many months/years after stroke. However, NHS speech and language therapy reduces in availability over time post stroke. Objective: This trial evaluated the clinical effectiveness and cost-effectiveness…